Helper-dependent adenoviral vector containing apoe
Helper-dependent adenoviral vector containing apoe has been studied in 1 paper since 2001: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Oct 30, 2001: “Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector”.
1 paper studies it2 findingsUpdated
See all 1 papers on helper-dependent adenoviral vector containing apoe
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Funders: National Heart, Lung, and Blood Institute and 1 more
- Animals1
What did studies of helper-dependent adenoviral vector containing apoe find?
2Studies of helper-dependent adenoviral vector containing apoe measured 2 outcomes: atherosclerotic lesion and hypercholesterolemia.
Atherosclerotic lesion
downin mice1
1 study
Atherosclerotic lesion
downin mice1
Helper-dependent adenoviral vector containing apoe protects against atherosclerotic lesion in apoE-deficient mice (essentially lesion-free vs 100%).
“At 2.5 years, control aorta was covered 100% by atherosclerotic lesion, whereas aorta of treated mice was essentially lesion-free.”
Animalsin apoE-deficient miceaorta2.5 years
Proceedings of the National Academy of Sciences of the United States of America
Hypercholesterolemia
downin mice1
1 study
Hypercholesterolemia
downin mice1
Helper-dependent adenoviral vector containing apoe prevents hypercholesterolemia in apoE-deficient mice.
“A single i.v. injection of this vector completely and stably corrected the hypercholesterolemia in apoE-deficient mice, an effect that lasted the natural lifespan of the mice.”
Animalsin apoE-deficient mice
Proceedings of the National Academy of Sciences of the United States of America